Lifeboat Foundation

Remote robotic-assisted surgery is far from new, with various educational and research institutions developing machines doctors can control from other locations over the years. There hasn’t been a lot of movement on that front when it comes to endovascular treatments for stroke patients, which is why a team of MIT engineers has been developing a telerobotic system surgeons can use over the past few years. The team, which has published its paper in Science Robotics, has now presented a robotic arm that doctors can control remotely using a modified joystick to treat stroke patients.

That arm has a magnet attached to its wrist, and surgeons can adjust its orientation to guide a magnetic wire through the patient’s arteries and vessels in order to remove blood clots in their brain. Similar to in-person procedures, surgeons will have to rely on live imaging to get to the blood clot, except the machine will allow them to treat patients not physically in the room with them.

Continue reading “MIT engineers built a robot for emergency stroke surgeries” »

The SENS Research Foundation Board of Directors has a singular focus – to help the Foundation develop, promote, and ensure widespread access to therapies that cure and prevent the diseases and disabilities of aging. As the body responsible for ensuring the organization’s alignment with its mission, it is important our Board comprise leaders within the longevity field – visionaries dedicated to defeating the effects of aging permanently.

Many supporters have followed with interest our recent separation from our co-Founder Dr. Aubrey de Grey, and some have expressed concern regarding the possibility of our mission focus drifting off course. We remain firmly on-mission and continue to make real progress in our field, however, we acknowledge that we are the foundation we are today because of Dr. de Grey’s vision and leadership within the longevity movement. With this in mind, we have formally offered Dr. de Grey a Directorship within the Board of Directors.

His installment as a Director will be effective immediately upon the successful completion of the recommendations made by the accredited professional he has personally engaged, with a subsequent letter of recommendation to the Board of Directors supporting Dr. de Grey’s ability to fulfill the duties of Directorship. In this capacity, Dr. de Grey would lend his expertise to help steer the vision of the Foundation. Consistent with good governance and past practices, Dr. de Grey and the other members of the Board will approve the annual budget, review the annual audit, interview and hire executives, act as advocates for SRF, and largely ensure that the mission is being adhered to by the organization.

Italian company EuroLink Systems, a technology solutions manufacturer with decades of industry experience, will launch the Beluga mini drone, a dual-use aircraft ready to deploy anywhere from the desert to the arctic, at next week’s Xponential 2022 in Orlando.

The new state-of-the-art multirotor drone blends a bio-inspired design with high-performance features that make it suitable for a wide variety of tasks – from military or public safety applications like short-range reconnaissance, search & rescue, or security applications to commercial use in 3D terrain mapping, urban logistics support applications, threat detections, and urgent medical transportation.

Beluga has been in development for three years and combines Eurolink Systems’ technical experience with mother nature shapes, resulting in an elegant design and rich technical functionality – that represents the best of art and science. The drone can fly fast, with a maximum cruising speed of up to 112 km/h (69 mph), for up to 60 minutes with a 3.3 lbs. (1.5 kg) payload.

For those not paying attention, Tesla has been unable to build cars in China for a few weeks as China shuts down due to a zero Covid policy. Here’s a short video about life in China:

China’s financial hub Shanghai has started easing its lockdown in some areas on Monday, despite reporting a record high of more than 25,000 new Covid-19 infections, as authorities sought to get the city moving again after more than two weeks.

Continue reading “Residents in locked down Shanghai scream from their balconies: ‘This cannot last’” »

Around the rim of the lens is an array of other electronics, including a custom-designed chip with a radio that streams content to the display and a variety of sensors, including an accelerometer, gyroscope, and magnetometer for tracking the user’s eye movements. This eye tracking capability not only ensures that AR imagery holds still as the user looks around, but also makes it possible to control the device through eye movements alone.

Despite their efforts to pack as much into the lens as possible, it won’t be a stand-alone piece of equipment. Most of the computing power required to run AR applications will be contained in a companion device worn around the neck, which will stream the content to the lens wirelessly.

The lens also hasn’t yet been cleared by the FDA for human use, so early demonstrations involve looking through a lens on a stick just in front of the eye. At present it is only capable of producing images in a green monochrome. But according to CNET , the device allows a user to select a variety of apps arranged in a ring around the periphery of their field of vision using nothing more than their gaze. These make it possible to do everything from checking flight information to using a compass to navigate and track fitness data like heart rate and lap number.

People with type O-blood are considered “universal donors” because their blood doesn’t have any antigens or proteins, meaning anybody’s body will be able to accept it in an emergency.

But why are there different blood types? Researchers don’t fully know, but factors such as where someone’s ancestors are from and past infections which spurred protective mutations in the blood may have contributed to the diversity, according to Dr. Douglas Guggenheim, a hematologist with Penn Medicine. People with type O blood may get sicker with cholera, for example, while people with type A or B blood may be more likely to experience blood clotting issues. While our blood can’t keep up with the different biological or viral threats going around in real time, it may reflect what’s happened in the past.

“In short, it’s almost like the body has evolved around its environment in order to protect it as best as possible,” Guggenheim says.

Therapies designed to increase T cell’s killing power and ability to target cancer after it appears have already been approved, and they can be quite successful at treating some cancers. (More recent work is recruiting another type of immune cell, the awesomely named natural killer cells, to fight cancer.)

Vaccines that prevent cancer caused by viruses, like hepatitis B and HPV, already exist, but the vast majority of cancers have other causes — inherited mutations, external causes (like smoking or UV exposure), or just random bad luck.

A vaccine against cancers caused by Lynch syndrome — an inherited disorder — will be among the first to test if a vaccine can stop nonviral cancers from appearing. The Lynch trial is among several looking to test a new generation of preventative cancer vaccines.

Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD

Papers referenced in the video:
Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan.
https://pubmed.ncbi.nlm.nih.gov/18599606/

Continue reading “AGE Products Impact Lifespan: Impact Of Hyperglycemia, Kidney Function, And The Microbiome” »